1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Small Grant Program (R03) is a grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH that supports investigator-initiated small research projects at the interface of biomedical, mathematical, physical, and engineering sciences.
NIBIB funds research focused on the discovery, development, and clinical translation of new technologies, as well as studies enabling fundamental biomedical discoveries with direct medical applications. Applicants must be highly qualified researchers affiliated with academic institutions pursuing interdisciplinary research with a preponderance of technological effort.
Award amounts, application deadlines, and specific eligibility requirements are governed by NIH's Parent R03 funding announcement (PA-20-200).
Get alerted about grants like this
Save a search for “National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Grant Program - R03 | National Institute of Biomedical Imaging and Bioengineering Small Grant Program - R03 The NIBIB provides support for Investigator-Initiated NIH Small Research Grant applications from highly qualified applicants who are poised to pursue research in interdisciplinary research at the interface between the biomedical and the mathematical, physical, or engineering sciences.
The NIBIB is interested in applications where the science is is focused on the discovery, development, and clinical translation of new existing technologies. The NIBIB is also interested in technological studies that enable fundamental biomedical discoveries across a broad spectrum of biological processes, disorders, and diseases and have significant potential for direct medical application.
The specific aims of an application for NIBIB funding, therefore, should involve a preponderance of technological effort. In most instances, technology development will occur in a vacuum, but will have a target medical application. However, in some instances, a technology-based application is so closely aligned to a specific disease or organ system that assignment to another NIH Institute will better serve the applicant.
Applicants are invited to look at the NIBIB Scientific Program Areas . For more information contact: Tatjana Atanasijevic, Ph. D.
Division of Applied Science and Technology National Institute of Biomedical Imaging and Bioengineering Email: Tatjana. Atanasijevic@nih. gov Access the NOFO here: PA-20-200: NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
According to the current listing, eligibility includes: Highly qualified applicants pursuing interdisciplinary biomedical research at academic institutions; must emphasize technological development with potential medical applications. Confirm the full requirements in the official notice before applying.
Small Grant Program – R03 is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NIBIB Trailblazer Award for New and Early Stage Investigators (R21) is a grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH that funds high-risk, high-impact research at the intersection of engineering, physical sciences, and biomedical sciences. Eligible applicants are NIH-defined New or Early Stage Investigators who have not previously submitted R01 or R15 applications. Awards provide $400,000 in direct costs over three years. No preliminary data are required — projects should be exploratory, novel, and non-incremental. Applications are due June 16, 2026.
Funding Opportunity Announcement for NIBIB Technology Development Network Coordinating Centers is a grant from the National Institutes of Health (NIH) through the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that will fund Coordinating Centers designed to bring together scientific and engineering communities to solve translational problems in biomedical technology development. The Coordinating Centers will facilitate collaborations across technology development projects, disseminate program advances, develop resources and outreach strategies for the broader biomedical research community, and manage an Opportunity Funds program to rapidly fund promising small-scale translational technology work. This Notice of Funding Opportunity uses the U24 activity code. Eligible applicants include nonprofits, public and private higher education institutions, and Native American tribal organizations. Applications are not currently being solicited; this notice is provided to allow potential applicants time to develop collaborations. Investigators with expertise in engineering and translation are encouraged to begin forming collaborative partnerships.
The Public Affairs Section (PAS) of the U.S. Embassy to the Kyrgyz Republic is soliciting project proposals from civil society and independent media organizations in the Kyrgyz Republic that focus on five priority areas specified below. Applicants should pay close attention to the Public Affairs Section’s priority goals, program areas, target audiences, and geographic locations when developing their proposals. Applicants are strongly encouraged to submit joint proposals with another NGO in the region or a Bishkek-based organization to build partnerships and strengthen civil society capacity in rural areas. This program will be funded under the Foreign Assistance Act authorization. All programming is subject to the statutory limitations of the funding determined. Please select one of the following five priority themes to focus on when developing your proposal: 1. Advancing Business Empowerment and Social Entrepreneurship 2. Promoting Democratic Institutions 3. Preventing Violent Extremism (PVE) 4. Trafficking-in-Persons (Anti-Trafficking) 5. Preventing Gender-Based Violence Funding Opportunity Number: STATE-BISHKEK-PAS-21-0002. Assistance Listing: 19.900. Funding Instrument: CA. Category: O. Award Amount: $10K – $50K per award.
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Supports clinical trials that prospectively assign human participants to conditions to assess biomedical or behavioral outcomes, focusing on fundamental aspects of phenomena without specific application towards processes or products in mind.
The April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read articleThe joint NSF-NIH Smart Health and Biomedical Research solicitation supports high-risk, high-reward AI/data science work in health — $300K per year for four years, with 20+ NIH institutes participating. Here is how the program actually selects winners.
Read article